IPVS webinar - HPV vaccine schedules and Sub-Saharan Africa

IPVS webinar – HPV vaccine schedules and Sub-Saharan Africa

Monday, 24th January 2022
12:00-13:30 EST (New York) / 18:00-19:30 CET (Geneva)

Topic:

Sub Saharan Africa (SSA) has a very high burden of cervical cancer. HPV vaccines are being introduced in many countries in the region but there are many challenges in implementation for the adolescent population. Two recent studies have recently reported at medical conferences (IPVC 34 Toronto) the interim results of trials with a 1 dose regimen of the bivalent vaccine Cervarix and the 9 valent vaccine Gardasil 9 to young girls and women.

In this webinar, the principal investigators of these trials, Dr Ruanne Barnabas, Dr Nelly Mugo, and Dr Deborah Watson-Jones will present their results and discuss the implications with respect to vaccine implementation and effectiveness in the SSA setting. SSA also has a high incidence of HIV infection and a frequently asked question concerns the potential impact of HIV infection on HPV vaccine effectiveness in SSA and this will be discussed by Dr Helen Rees.

Moderator:
Margaret Stanley
Professor
University of Cambridge

Speakers:
Ruanne Barnabas
Professor
University of Washington, USA

Nelly Mugo
Associate Research Professor
Department of Global Health, University of Washington
Center for Clinical Research, Kenya Medical Research Institute

Helen Rees
Professor
Wits RHI at the University of Witwatersrand

Deborah Watson-Jones
Professor
Mwanza Intervention Trials Unit, National Institute for Medical Research

This webinar is LIVE and FREE of charge.
Attendees can claim their certificate of participation after the webinar.